Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance

Go back to Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance

Repligen (RGEN) Tops Q2 EPS by 15c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus

July 30, 2020 7:35 AM EDT

Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.42, $0.15 better than the analyst estimate of $0.27. Revenue for the quarter came in at $87.5 million versus the consensus estimate of $78.38 million.

Reports record quarterly revenue of $87.5 millionOverall revenue grew 24% year-over-year, with organic growth of 19%Raises revenue guidance to $332-$340 million for full year 2020, representing 18%-21% organic growthCompletes acquisition of silicone molding and tubing manufacturer Engineered Molding Technology

Tony J. Hunt, President and Chief Executive Officer said, Im pleased to report that the company delivered outstanding financial performance during the second... More